PMV PHARMACEUTICALS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PMV PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $10.00K.
- PMV PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $51.00K, a 750.00% increase year-over-year.
- PMV PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $105.00K, a 61.96% decline year-over-year.
- PMV PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $12.00K, a 90.63% decline year-over-year.
- PMV PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $6.00K, a 94.00% decline from fiscal 2019.
- PMV PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $100.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-03-31 | $10.00K 10-Q · filed 2026-08-14 | |
| 2023-09-30 | $51.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $105.00K 10-Q · filed 2023-11-09 | |
| 2023-03-31 | $12.00K 10-Q · filed 2024-11-07 | |
| 2022-09-30 | $6.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $276.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $128.00K 10-Q · filed 2023-11-09 | |
| 2021-09-30 | $309.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.26M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $162.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $6.00K 10-K · filed 2023-03-01 | |
| 2019-12-31 | $100.00K 10-K · filed 2022-03-01 | |
| 2019-06-30 | $100.00K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |